Dodani Sunita
Medical College of Georgia, Augusta, GA 30912, USA.
Vasc Health Risk Manag. 2008;4(5):953-61. doi: 10.2147/vhrm.s2915.
BACKGROUND: Coronary artery disease (CAD) is the leading cause of mortality and morbidity in the United States (US), and South Asian immigrants (SAIs) have a higher risk of CAD compared to Caucasians. Traditional risk factors may not completely explain high risk, and some of the unknown risk factors need to be explored. This short review is mainly focused on the possible role of dysfunctional high-density lipoprotein (HDL) in causing CAD and presents an overview of available literature on dysfunctional HDL. DISCUSSION: The conventional risk factors, insulin resistance parameters, and metabolic syndrome, although important in predicting CAD risk, may not sufficiently predict risk in SAIs. HDL has antioxidant, antiinflammatory, and antithrombotic properties that contribute to its function as an antiatherogenic agent. Recent Caucasian studies have shown HDL is not only ineffective as an antioxidant but, paradoxically, appears to be prooxidant, and has been found to be associated with CAD. Several causes have been hypothesized for HDL to become dysfunctional, including Apo lipoprotein A-I (Apo A-I) polymorphisms. New risk factors and markers like dysfunctional HDL and genetic polymorphisms may be associated with CAD. CONCLUSIONS: More research is required in SAIs to explore associations with CAD and to enhance early detection and prevention of CAD in this high risk group.
背景:冠状动脉疾病(CAD)是美国死亡和发病的主要原因,与白种人相比,南亚移民(SAIs)患CAD的风险更高。传统风险因素可能无法完全解释其高风险,一些未知风险因素有待探索。本简短综述主要关注功能失调的高密度脂蛋白(HDL)在引发CAD中可能发挥的作用,并概述有关功能失调HDL的现有文献。 讨论:传统风险因素、胰岛素抵抗参数和代谢综合征,尽管在预测CAD风险方面很重要,但可能不足以预测SAIs的风险。HDL具有抗氧化、抗炎和抗血栓形成特性,有助于其作为抗动脉粥样硬化剂发挥作用。最近针对白种人的研究表明,HDL不仅作为抗氧化剂无效,而且矛盾的是,似乎具有促氧化作用,并且已发现其与CAD有关。已对HDL功能失调的几种原因进行了假设,包括载脂蛋白A-I(Apo A-I)多态性。功能失调的HDL和基因多态性等新的风险因素和标志物可能与CAD有关。 结论:需要对SAIs进行更多研究,以探索与CAD的关联,并加强对这一高风险群体CAD的早期检测和预防。
Int J Cardiol. 2008-9-16
J Immigr Minor Health. 2008-9-24
Inflamm Allergy Drug Targets. 2010-12
Lipids Health Dis. 2011-3-16
J Racial Ethn Health Disparities. 2023-6
Dialogues Health. 2023-5-18
J Racial Ethn Health Disparities. 2023-6
Curr Cardiovasc Risk Rep. 2019-8
Curr Diabetes Rev. 2021
JRSM Cardiovasc Dis. 2018-12-12
BMC Musculoskelet Disord. 2017-8-23
Indian Heart J. 2017
Indian J Hum Genet. 2008-1
Int J Cardiol. 2008-9-16
Rev Cardiovasc Med. 2007
Curr Atheroscler Rep. 2007-1
Indian J Med Res. 2006-9
Nat Clin Pract Endocrinol Metab. 2006-9
Curr Atheroscler Rep. 2006-9